Article Details

Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $133

Retrieved on: 2025-10-06 14:02:36

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $133. View article details on hiswai:

Excerpt

MorganStanley analyst Terence Flynn maintains $BioNTech(BNTX.US)$ with a buy rating, and maintains the target price at $133.

Article found on: news.futunn.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo